Th2 Cytokines Are Associated with Persistent Hepatic Fibrosis in Human Schistosoma japonicum Infection
1Center for International Health Research, Rhode Island Hospital, and 2Epidemiology Section, 3Department of Community Health and International Health Institute, and 4Center for Statistical Sciences, Brown University, and Departments of 5Pediatrics and 6Pathology and Laboratory Medicine, Brown University Medical School, Providence, Rhode Island; 7Research Institute of Tropical Medicine, Manila, the Philippines
We conducted a prospective cohort study in Leyte, the Philippines, among 611 Schistosoma japonicum–infected participants 7–30 years old, all of whom were treated with praziquantel at baseline. To detect hepatic fibrosis, abdominal ultrasound was performed at baseline and 12 months after treatment. Stool for assessment of S. japonicum infection was collected at baseline and at 3, 6, 9, and 12 months after treatment. Cytokines (interleukin [IL]–4, IL‐5, IL‐10, IL‐13, tumor necrosis factor–α, and interferon‐γ) produced by peripheral‐blood mononuclear cells in response to soluble worm antigen preparation (SWAP), soluble egg antigen (SEA), and control medium were measured once 4 weeks after treatment. IL‐4 to SWAP and IL‐10 to both SWAP and SEA were associated with the presence of baseline fibrosis after adjustment for potential confounding variables (
, for all). In participants with fibrosis at baseline, IL‐4 to SWAP and IL‐5 and IL‐13 to both SWAP and SEA were associated with persistent fibrosis at 12 months after treatment (
, for all). Males showed consistently stronger T helper 2 (Th2) cytokine responses to both SWAP and SEA than did females (
, for all). These results suggest an independent role for Th2‐biased cytokine responses to S. japonicum antigens in persistent hepatic fibrosis and indicate that Th2 cytokines may contribute to the male‐biased prevalence of fibrosis.
Received 11 June 2006; accepted 11 September 2006; electronically published 13 December 2006.
Cited by
Online publication date: 17-Jul-2009.
CrossRef
Online publication date: 1-May-2009.
CrossRef
Online publication date: 1-Jan-2009.
CrossRef
Online publication date: 1-Aug-2008.
-
Potential conflicts of interest: none reported.
Financial support: National Institutes of Health (grants R01AI48123 and K23AI52125).





